Back to School: How biopharma can reboot drug development. Access exclusive analysis here

ArQule, Monsanto deal

The companies extended for an additional year through 2002 their 1996 agreement granting MTC access to

Read the full 165 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE